FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313648298> ?p ?o ?g. }

• W4313648298 abstract "Abstract Background Triple-Negative Breast Cancer (TNBC) is a subtype of breast cancer that differs from other types of breast cancers in the faster spread and worse outcome. TNBC presented limited treatment options. BET (Bromodomain and extra-terminal domain) proteins are epigenetic readers that control the expression of different oncogenic proteins, and their inhibition (BETi) is considered a promising anti-cancer strategy. Recent evidence demonstrated the involvement of BET proteins in regulation of metabolic processes. Methods MDA-MB231 cells treated with JQ1 followed by RNA-sequencing analysis showed altered expression of lipid metabolic genes; among these, we focused on ATGL, a lipase required for efficient mobilization of triglyceride. Different in vitro approaches were performed to validate the RNA-sequencing data (qRT-PCR, immunofluorescence and flow cytometry). NMR (Nuclear Magnetic Resonance) was used to analyze the lipid reprogramming upon treatment. ATGL expression was determined by immunoblot and qRT-PCR, and the impact of ATGL function or protein knockdown, alone and in combination with BETi, was assessed by analyzing cell proliferation, mitochondrial function, and metabolic activity in TNBC and non-TNBC cells culture models. Results TNBC cells treated with two BETi markedly increased ATGL expression and lipolytic function and decreased intracellular lipid content in a dose and time-dependent manner. The intracellular composition of fatty acids (FAs) after BETi treatment reflected a significant reduction in neutral lipids. The short-chain FA propionate entered directly into the mitochondria mimicking ATGL activity. ATGL KD (knockdown) modulated the levels of SOD1 and CPT1a decreasing ROS and helped to downregulate the expression of mitochondrial ß-oxidation genes in favor of the upregulation of glycolytic markers. The enhanced glycolysis is reflected by the increased of the mitochondrial activity (MTT assay). Finally, we found that after BETi treatment, the FoxO1 protein is upregulated and binds to the PNPLA2 promoter leading to the induction of ATGL. However, FoxO1 only partially prompted the induction of ATGL expression by BETi. Conclusions The anti-proliferative effect achieved by BETi is helped by ATGL mediating lipolysis. This study showed that BETi altered the mitochondrial dynamics taking advantage of ATGL function to induce cell cycle arrest and cell death. Graphical Abstract Schematic representation of BETi mechanism of action on ATGL in TNBC cells. BETi induce the expression of FoxO1 and ATGL, lowering the expression of G0G2, leading to a switch in metabolic status. The induced expression of ATGL leads to increased lipolysis and a decrease in lipid droplet content and bioavailability of neutral lipid. At the same time, the mitochondria are enriched with fatty acids. This cellular status inhibits cell proliferation and increases ROS production and mitochondrial stress. Interfering for ATGL expression, the oxidative phenotypic status mildly reverted to a glycolytic status where neutral lipids are stored into lipid droplets with a consequent reduction of oxidative stress in the mitochondrial." @default.
• W4313648298 created "2023-01-07" @default.
• W4313648298 creator A5007012775 @default.
• W4313648298 creator A5014045886 @default.
• W4313648298 creator A5016637178 @default.
• W4313648298 creator A5042559824 @default.
• W4313648298 creator A5054158026 @default.
• W4313648298 creator A5060459819 @default.
• W4313648298 creator A5062978183 @default.
• W4313648298 creator A5067368179 @default.
• W4313648298 creator A5079447202 @default.
• W4313648298 date "2023-01-06" @default.
• W4313648298 modified "2023-10-12" @default.
• W4313648298 title "BETi enhance ATGL expression and its lipase activity to exert their antitumoral effects in triple-negative breast cancer (TNBC) cells" @default.
• W4313648298 cites W1980568044 @default.
• W4313648298 cites W1983011772 @default.
• W4313648298 cites W1990763472 @default.
• W4313648298 cites W1994146146 @default.
• W4313648298 cites W2010819467 @default.
• W4313648298 cites W2014349355 @default.
• W4313648298 cites W2056633943 @default.
• W4313648298 cites W2057001750 @default.
• W4313648298 cites W2057460011 @default.
• W4313648298 cites W2072525612 @default.
• W4313648298 cites W2084600354 @default.
• W4313648298 cites W2099540110 @default.
• W4313648298 cites W2112520822 @default.
• W4313648298 cites W2117692326 @default.
• W4313648298 cites W2127694087 @default.
• W4313648298 cites W2150101070 @default.
• W4313648298 cites W2234115940 @default.
• W4313648298 cites W2466685748 @default.
• W4313648298 cites W2508519535 @default.
• W4313648298 cites W2523687917 @default.
• W4313648298 cites W2589120174 @default.
• W4313648298 cites W2607120474 @default.
• W4313648298 cites W2729569907 @default.
• W4313648298 cites W2779743226 @default.
• W4313648298 cites W2793787097 @default.
• W4313648298 cites W2803008706 @default.
• W4313648298 cites W2805393256 @default.
• W4313648298 cites W2897810065 @default.
• W4313648298 cites W2901762571 @default.
• W4313648298 cites W2903107073 @default.
• W4313648298 cites W2939427895 @default.
• W4313648298 cites W2945068621 @default.
• W4313648298 cites W2951348608 @default.
• W4313648298 cites W2980402980 @default.
• W4313648298 cites W2996820863 @default.
• W4313648298 cites W3003289692 @default.
• W4313648298 cites W3005474073 @default.
• W4313648298 cites W3006355107 @default.
• W4313648298 cites W3013544658 @default.
• W4313648298 cites W3025964579 @default.
• W4313648298 cites W3054603086 @default.
• W4313648298 cites W3124600981 @default.
• W4313648298 cites W3127705529 @default.
• W4313648298 cites W3133759463 @default.
• W4313648298 cites W3181293620 @default.
• W4313648298 cites W3200114420 @default.
• W4313648298 cites W3217598064 @default.
• W4313648298 doi "https://doi.org/10.1186/s13046-022-02571-3" @default.
• W4313648298 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36604676" @default.
• W4313648298 hasPublicationYear "2023" @default.
• W4313648298 type Work @default.
• W4313648298 citedByCount "1" @default.
• W4313648298 countsByYear W43136482982023 @default.
• W4313648298 crossrefType "journal-article" @default.
• W4313648298 hasAuthorship W4313648298A5007012775 @default.
• W4313648298 hasAuthorship W4313648298A5014045886 @default.
• W4313648298 hasAuthorship W4313648298A5016637178 @default.
• W4313648298 hasAuthorship W4313648298A5042559824 @default.
• W4313648298 hasAuthorship W4313648298A5054158026 @default.
• W4313648298 hasAuthorship W4313648298A5060459819 @default.
• W4313648298 hasAuthorship W4313648298A5062978183 @default.
• W4313648298 hasAuthorship W4313648298A5067368179 @default.
• W4313648298 hasAuthorship W4313648298A5079447202 @default.
• W4313648298 hasBestOaLocation W43136482981 @default.
• W4313648298 hasConcept C104317684 @default.
• W4313648298 hasConcept C121608353 @default.
• W4313648298 hasConcept C127561419 @default.
• W4313648298 hasConcept C173396325 @default.
• W4313648298 hasConcept C181199279 @default.
• W4313648298 hasConcept C185592680 @default.
• W4313648298 hasConcept C190283241 @default.
• W4313648298 hasConcept C25095133 @default.
• W4313648298 hasConcept C2777062983 @default.
• W4313648298 hasConcept C2779697368 @default.
• W4313648298 hasConcept C2780110267 @default.
• W4313648298 hasConcept C2781018059 @default.
• W4313648298 hasConcept C29537977 @default.
• W4313648298 hasConcept C4733338 @default.
• W4313648298 hasConcept C502942594 @default.
• W4313648298 hasConcept C530470458 @default.
• W4313648298 hasConcept C54355233 @default.
• W4313648298 hasConcept C55493867 @default.
• W4313648298 hasConcept C86803240 @default.
• W4313648298 hasConcept C95444343 @default.
• W4313648298 hasConceptScore W4313648298C104317684 @default.
• W4313648298 hasConceptScore W4313648298C121608353 @default.

• next